Clinical Dilemmas in Non-Alcoholic Fatty Liver Disease (Clinical Dilemmas (UK))

Clinical Dilemmas in Non-Alcoholic Fatty Liver Disease offers hepatologists practical, up-to-date and expert guidance on the most topical dilemmas, difficulties and areas of controversy/difficulty surrounding this ever-increasing area of liver disease they face in daily practice. Roger Williams and Simon Taylor-Robinson, two of Europe’s leading hepatologists, have recruited leading figures from across the world to assist them, resulting in a truly international approach. Each chapter covers a specific area of difficulty, containing clear learning points and providing evidence-based expert guidance on the latest hot topics in clinical management such as: Is NAFLD different in absence of Metabolic Syndrome? Are the pros outweighed by the cons of obtaining a liver biopsy? Is progression to cirrhosis more likely in children with NAFLD? What are the dangers as well as the true benefits of bariatric surgery? How is it best to use antifibrotic agents in clinical practice? Clinical Dilemmas in Non-Alcoholic Fatty Liver Disease provides the answers to the questions and challenges that clinicians face every day in this area. It is essential reading for hepatologists of all levels and researchers in hepatology, as well as all those involved in the care of patients with NAFLD, including gastroenterologists, pathologists and specialist hepatology nurses. Hype Or Harm From Fatty Liver Disease? / Stephen H Caldwell And Curt Argo -- Worldwide Problem / Geoffrey Farrell And Philip Newsome -- Is Insulin Resistance The Key Motive For Nafld? / Desmond Johnston -- Progression To Cirrhosis Is More Likely In Children With Nafld? / Anil Dhawan -- Nafld As Cause Of Cryptogenic Cirrhosis? / Jay Lefkowitch -- Is Nafld Different In Absence Of Metabolic Syndrome? / Yusuf Yilmaz -- Occurrence Of Noncirrhotic Hcc In Nafld / Stephen Harrison And Dawn Torres -- Fibrosis Progression Molecular Pathways All Important? / Anna-mae Diehl And Dr Wing-kin Syn -- Can Fatty Liver Of Nafld Be Distinguished From That Of Alcoholic Liver Disease? / David Kleiner And Elizabeth Brunt -- Are Inflammasomes And Intestinal Microbiota Relevant In Disease Progression To Nash? / M. Bilal Siddiqui, M. Shadab Siddiqui And Arun Sanyal -- Can Genetic Influence In Non-alcoholic Fatty Liver Disease Be Ignored? / Quentin Anstee --^ Is There A Mechanistic Link Between Hepatic Steatosis And Cardiac Rather Than Liver Events? / Soo Lim -- Is There A Best Method For Diagnosis Of Nafld? / Vlad Ratziu -- Choice Of Non-invasive Blood Tests And Fibroscan / Massimo Pinzani And Manolis Tsocatzis -- Are The Guidelines Aasld, Iasl, Easl And Bsg Of Help? / Jean-francois Dufour -- How To Choose From Different Imaging Modalities And Screening Techniques / Hero Hussain -- Are The Pros Outweighed By The Cons Of Obtaining A Liver Biopsy? / Simon Taylor-robinson And Jeremy Cobbold -- Screening For Nafld In High Risk Population / Nader Lessan -- Balancing Calorie Restriction, Exercise And Weight Reduction / Nicholas Finer -- Should Physicians Be Prescribing, Or Patients Self-medicating With Orlistat, Vitamin E, Vitamin D, Insulin Antagonist, Trental And Coffee? / Brent Neuschwander-tetri And Haripriya Maddur --^ Does Improvement In Hepatic Steatosis Have A Significant Favourable Effect On The Metabolic Syndrome, Including Diabetes? / Jukka Westerbacka -- What Are The Dangers As Well As The True Benefits Of Bariatric Surgery? / Andrew Jenkinson -- Liver Transplantation : What Can It Offer? / Roger Williams -- Molecular Antagonists, Leptin Or Other Hormones In Supplementing Environmental Factors? / Jeremy Tomlinson -- Use Of Antifibrotic Agents In Clinical Practice / Jonathan Fallowfield -- Better Understanding Of Early Development And Material Influence? / Jude Oben -- Defining The Role Of Metabolic Physician / Nicholas Finer. [edited By] Roger Williams, Simon Taylor-robinson. Includes Bibliographical References And Index. Mode Of Access: World Wide Web. 'Clinical Dilemmas in Non-Alcoholic Fatty Liver Disease' offers hepatologists practical, up-to-date and expert guidance on the most topical dilemmas, difficulties and areas of controversy/difficulty surrounding this ever-increasing area of liver disease they face in daily practice. Clinical Dilemmas in Non-Alcoholic Fatty Liver Disease offers hepatologists practical, up-to-date and expert guidance on the most topical dilemmas, difficulties and areas of controversy/difficulty surrounding this ever-increasing area of liver disease they face in daily practice. Roger Williams and Simon Taylor-Robinson, two of Europe's leading hepatologists, have recruited leading figures from across the world to assist them, resulting in a truly international approach. Each chapter covers a specific area of difficulty, containing clear learning points and providing evidence-basedexpert guidance on the latest hot topics in clinical management such as: Is NAFLD different in absence of Metabolic Syndrome? Are the pros outweighed by the cons of obtaining a liver biopsy? Is progression to cirrhosis more likely in children with NAFLD? What are the dangers as well as the true benefits of bariatric surgery? How is it best to use antifibrotic agents in clinical practice? Clinical Dilemmas in Non-Alcoholic Fatty Liver Disease provides the answers to the questions and challenges that clinicians face every day in this area. It is essential reading for hepatologists of all levels and researchers in hepatology, as well asall thoseinvolved in the care of patients with NAFLD, including gastroenterologists, pathologistsand specialist hepatology nurses __Clinical Dilemmas in Non-Alcoholic__ __Fatty Liver Disease__ offers hepatologists practical, up-to-date and expert guidance on the most topical dilemmas, difficulties and areas of controversy/difficulty surrounding this ever-increasing area of liver disease they face in daily practice. Roger Williams and Simon Taylor-Robinson, two of Europe’s leading hepatologists, have recruited leading figures from across the world to assist them, resulting in a truly international approach. Each chapter covers a specific area of difficulty, containing clear learning points and providing evidence-based expert guidance on the latest hot topics in clinical management such as: * Is NAFLD different in absence of Metabolic Syndrome? * Are the pros outweighed by the cons of obtaining a liver biopsy? * Is progression to cirrhosis more likely in children with NAFLD? * What are the dangers as well as the true benefits of bariatric surgery? * How is it best to use antifibrotic agents in clinical practice?